Panelists discuss the emotional and diagnostic journey of a multiple myeloma patient and his care partner, highlighting how ...

Patient-reported outcomes could have a prognostic and predictive impact on care for multiple myeloma.A retrospective analysis ...

The FDA approved Lynozyfic (linvoseltamab-gcpt) to treat adults with relapsed/refractory multiple myeloma who have received at least 4 prior lines of therapy.

A study led by Cambridge researchers has shed light on how neural stem cell grafts could help restore myelin in the central ...

UCLA Health researchers have identified four distinct pathways that lead to Alzheimer's disease by analyzing electronic ...

Head and neck cancers (HNCs) form a diverse group of malignant tumors originating in the upper aerodigestive tract, ranking ...